Proteome Sciences plc
(the "Proteome Sciences" or "Company")
Change of Broker Name
Following its change of name from Landsbanki Securities (UK) Limited to
Teathers Limited on 7 October 2008, the name of the Company's broker and NOMAD
is now Teathers Limited of:
Beaufort House
15 St Botolph Street
London EC3A 7QR
Ends
For further information please contact:
Proteome Sciences plc
www.proteomics.com Tel: +44 (0)1932 865065
Christopher Pearce, Chief Executive James Malthouse, Finance Director
Email: christopher.pearce@proteomics.com Email: james.malthouse@proteomics.com
Public Relations
IKON Associates Coast Communications
Adrian Shaw Matt Baldwin
Tel: +44 (0)1483 535102 Tel: +44 (0)1233 503200
Mobile: +44 (0)797 9900733 Mobile: +44 (0)7930 439739
Email: adrian@ikonassociates.com Email: matt@coastcommunications.com
Nominated Adviser
Teathers Limited
Shaun Dobson / Claes Spång
Tel: +44 (0)20 7426 9000
About Proteome Sciences:
Proteome Sciences plc (LSE : PRM) is a global leader in applied proteomics,
using high sensitivity proprietary techniques to detect and characterise
differentially expressed proteins in diseases for diagnostic, prognostic and
therapeutic applications.
ProteoSHOP® provides integrated proteomic services for biomarker discovery,
validation and measurement in clinical trials and in vitro diagnostics. Key
features include the proprietary isobaric tandem mass tag technology TMT® for
accurate and reliable biomarker quantification and the ability to rapidly
develop highly reproducible quantitative biomarker assays.
The main focus of its research addresses neurological, oncology and
cardiovascular conditions and has discovered blood biomarkers in stroke, brain
damage, solid organ transplant rejection and Alzheimer's disease. Proteome
Sciences is based in Cobham, UK with facilities in London and Frankfurt.